SCHEMBL21532409

SCHEMBL21532409

c1ccc(-c2nnn(-c3cccc4c3c3ccccc3n4-c3ccccc3-n3c4ccccc4c4c3ccc3c5ccccc5n(-c5ccccc5)c34)c2-c2ccccc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ATM Q13315 1/20 0.34
IL1R1 P14778 1/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
HTT P42858 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.31
MAPK1 P28482 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
ADORA2B P29275 1/20 0.30
ADORA1 P30542 1/20 0.30
DHODH Q02127 1/20 0.30
MGAM O43451 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532147 0.96 NPC1 (0.36) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E
SCHEMBL21532476 0.94 L3MBTL1 (0.35) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E
SCHEMBL21532154 0.90 RAC2 (0.35) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E
SCHEMBL21532145 0.90 NPC1 (0.35) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E
SCHEMBL21532772 0.90 L3MBTL1 (0.35) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E
SCHEMBL21532360 0.90 IDO1 (0.37) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E
SCHEMBL21532733 0.90 IDO1 (0.37) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E
SCHEMBL21532347 0.89 NPC1 (0.36) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E
SCHEMBL21532345 0.89 NPC1 (0.36) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E
SCHEMBL15762174 0.88 KDM4E (0.41) SMN1; SMN2NPC1RAB9AL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 SMN1; SMN2 2430/4885NPC1 1879/4885RAB9A 1780/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 SMN1; SMN2 2103/4885NPC1 2440/4885RAB9A 2046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.